Arena Investors’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Arena Investors’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-126,122	Closed	-$2.4K	–	90
2023 Q1	$2.4K	Hold	126,122	–	–	﹤0.01%	75
2022 Q4	$18.8K	Hold	126,122	–	–	0.02%	68
2022 Q3	$21.4K	Hold	126,122	–	–	0.01%	117
2022 Q2	$20K	Hold	126,122	–	–	0.01%	130
2022 Q1	$100K	Hold	126,122	–	–	0.07%	79
2021 Q4	$75.7K	Buy	+126,122	New	+$128K	0.08%	25

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Arena Investors's PEARW Position: Q2 2023 in Review

Arena Investors sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 126,122 shares — an estimated $2.4K sold.

Arena Investors first reported a position in PEARW in Q4 2021 and held it in 6 quarters. The position peaked at $100K in Q1 2022. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Arena Investors reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Arena Investors sold 126,122 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $2.4K.
Arena Investors first reported a position in Pear Therapeutics, Inc. Warrant in Q4 2021 and held it in 6 quarters.
Arena Investors's Pear Therapeutics, Inc. Warrant position peaked at $100K in Q1 2022.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Arena Investors's 13F filing for Q2 2023, filed 14 Aug 2023.